Q8TEK3 (DOT1L_HUMAN) Homo sapiens (Human)

Histone-lysine N-methyltransferase, H3 lysine-79 specific UniProtKBInterProSTRINGInteractive Modelling

1537 aa; Sequence (Fasta) ; (Isoform 1)

Available Structures

48 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Active state Dot1L bound to the H2B-Ubiquitinated nucleosome, 2-to-1 complex Heteromer
P02281; P06897; P0CG47; P62799; P84233;
4-332
SAM;
Assess
Active state Dot1L bound to the H2B-Ubiquitinated nucleosome, 1-to-1 complex Heteromer
P02281; P06897; P0CG48; P62799; P84233;
4-331
SAM;
Assess
cryo-EM structure of DOT1L bound to unmodified nucleosome Heteromer
P02281; P62799; P84233; Q6AZJ8;
5-332
SAM;
Assess
Structure of Dot1L-H2BK120ub nucleosome complex Heteromer
F5H388; P02281; P06897; P62799; P84233;
5-332
Assess
Structure of Dot1L-H2BK34ub Nucleosome Complex Heteromer
O60814; P04908; P62805; P62979; P68431;
5-332
SAH;
Assess
cryo-EM structure of DOT1L bound to H2B ubiquitinated nucleosome Heteromer
P02281; P0CG47; P62799; P84233; Q6AZJ8;
5-332
SAM;
Assess
Dot1L bound to the H2BK120 Ubiquitinated nucleosome Heteromer
P02281; P06897; P0CG47; P62799; P84233;
5-332
SAH;
Assess
Cryo-EM structure of Dot1L and H2BK34ub-H3K79Nle nucleosome 2:1 complex Heteromer
O60814; P04908; P0CG47; P62805; Q71DI3;
5-332
SAM;
Assess
Cryo-EM structure of Dot1L and H2BK34ub-H3K79Nle nucleosome 1:1 complex Heteromer
O60814; P04908; P0CG47; P62805; Q71DI3;
5-332
SAM;
Assess
Poised-state Dot1L bound to the H2B-Ubiquitinated nucleosome Heteromer
J3QS39; P02281; P06897; P62799; P84233;
4-330
Assess
Cryo-EM structure of human DOT1L in complex with an H2B-monoubiquitinated nucleosome Heteromer
A0A310TTQ1; P02281; P62799; P62979; Q6AZJ8;
8-331
SAH;
Assess
Crystal structure of the coiled-coil domains of human DOT1L in complex with AF10 Heteromer
P55197;
483-549
Assess
Crystal structure of AF10-DOT1L complex Heteromer
Q5JT35;
610-649
Assess
Solution NMR structure of DOT1L in complex with AF9 (DOT1L-AF9) Heteromer
P42568;
877-900
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH DOT1L(998-1006) PHOSPHOPEPTIDE Heteromer
P01889; P61769;
998-1006
GLC;
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH DOT1L(998-1006) PEPTIDE Heteromer
P01889; P61769;
998-1006
GLC;NA;
Assess
Crystal structure of Dot1L in complex with adenosine and inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6…homo-2-mer4-332
ADN;5JJ;TLA;
Assess
Structure-Guided DOT1L Probe Optimization by Label-Free Ligand Displacementmonomer4-347
3US;SO4;GOL;EDO;
Assess
Crystal structure of Dot1l in complex with 5-iodotubercidinmonomer4-344
5ID;IOD;NA;UNX;
Assess
Crystal Structure of human DOT1L in complex with inhibitor SGC0947monomer4-342
AW3;GOL;
Assess
Crystal structure of human DOT1L in complex with inhibitor FED2monomer5-342
AW0;UNX;
Assess
Crystal structure of human DOT1L in complex with inhibitor SGC0946monomer4-341
BR;AW2;NA;
Assess
Crystal structure of human DOT1L in complex with 2 molecules of EPZ004777monomer4-341
0QK;UNX;
Assess
Crystal Structure of human DOT1L in complex with inhibitor FED1monomer4-339
AW1;UNX;
Assess
Crystal Structure of DOT1L in Complex with EPZ-5676monomer4-334
EP6;SO4;
Assess
complex of Dot1l with SS148monomer4-332
22×UNX;6NR;
Assess
Crystal structure of Dot1l in complex with a brominated SAH analogmonomer4-332
SX0;SO4; 20×UNX;
Assess
Crystal structure of Dot1L in complex with an inhibitor (compound 3).monomer5-332
N4W;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6-(pent-2-yn-1-…monomer5-332
5JJ;5JT;TLA;
Assess
Crystal structure of Dot1L in complex with an inhibitor (compound 10).monomer5-332
N4Z;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD1 [4-(2,6-dichlorobenzoyl)-N-methyl-1H-pyrr…monomer5-332
5F4;
Assess
Crystal structure of Dot1L in complex with an inhibitor (compound 11).monomer5-332
N5K;SO4;
Assess
DOT1L structure in complex with SAHmonomer5-332
SAH;SO4;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD5 [N-(2,6-dichlorophenyl)-4-methoxy-N-methy…monomer5-332
5F7;
Assess
Crystal Structure of Human DOT1L in complex with inhibitor EPZ004777monomer4-331
0QK;SO4;EDO;UNX;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD10 [6'-chloro-1,4-dimethyl-5'-(2-methyl-6-(…monomer5-332
K;5EW;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD3 [N-(1-(2-chlorophenyl)-1H-indol-6-yl)-2-(…monomer5-332
K;5EK;
Assess
Crystal structure of DOT1L in complex with EPZ000004monomer5-332
EP4;SO4;GOL;
Assess
Structure of the Catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransf…monomer5-332
ACT;SO4;SAM;
Assess
Crystal Structure of Human DOT1L in Complex with a Selective Inhibitormonomer5-332
TT8;GOL;ACT;SO4;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD3 [(2,6-dichlorophenyl)(quinolin-6-yl)metha…monomer5-332
5F6;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD2 [2-(2-(5-((2-chlorophenoxy)methyl)-1H-tet…monomer5-332
5EG;
Assess
DOT1L Structure in complex with SAMmonomer4-330
SAM;SO4;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD7 [N-(3-(((R)-1-(7H-pyrrolo[2,3-d]pyrimidin…monomer5-331
5JU;SO4;
Assess
Crystal structure of Dot1L in complex with inhibitor CPD11 [N4-methyl-N2-(2-methyl-1-(2-phenoxyphen…monomer5-331
5EV;SO4;
Assess
Crystal Structure of DOT1L in Complex with EPZ003696monomer5-331
0QJ;
Assess
Crystal Structure of DOT1L in complex with EPZ004777monomer4-330
0QK;SO4;
Assess
Crystal structure of DOT1L in complex with 18-Crown-6monomer5-330
O4B;SAH;SO4;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3uwp.1.Amonomer0.784-344
5ID;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 13uwp.1.Amonomer0.784-344
5ID;100.00
Assess